AntBio specializes in the research and development of recombinant antibodies and proteins, as well as various assay reagents for basic research, drug development, cell therapy, gene therapy, and in vitro diagnostics. Our product portfolio includes high-quality antibodies, target proteins, cytokines, enzymes, and assay kits, aiming to provide high-quality products and professional services to customers in the life sciences.
Ambeed Inc.
Ambeed is a trusted research supplier supporting oncology discovery from early chemistry through translational biology worldwide. We provide high-quality building blocks, advanced intermediates, inhibitors, peptides, bio-conjugation reagents, recombinant proteins, antibodies, and custom synthesis support for academic labs, biotech companies, CROs, and pharmaceutical teams. Our portfolio is well aligned with AACR 2026’s emphasis on precision, partnership, and purpose across cancer biology, translational research, therapeutics, biomarkers, and clinical innovation. Backed by a broad in-stock inventory, Ambeed offers more than 11,000 inhibitors and agonists, 13,000 fluorinated building blocks, 7,000 amino acids and peptides, 7,000 boronic acids and esters, and 5,000 XDCs and PROTAC-related products, alongside additional core categories for hit-to-lead and oncology research. Our materials are supported by responsive service, flexible sourcing, and quality-focused manufacturing capabilities, including scale-up support up to 100 kg, a 300,000 sq. ft. facility, and a team of over 200 scientists. Stop by our booth and let’s explore how we can strengthen your ongoing pipelines.
Almac Group
Almac Diagnostic Services We are a precision medicine company specialising in biomarker driven clinical trials. Our global CLIA and CAP accredited laboratories cover UK, Europe, USA and APAC regions. Our cores services: * Multi-Omic Services: We offer a range of genomic & proteomic platform and chemistry options, alongside expert data sciences support & a specialty central lab service. * Clinical Biomarker & CDx Development: Custom Clinical Biomarker & CDx development, validation & delivery service from our CLIA & CAP accredited laboratories in USA, Europe and APAC. * Clinical Testing: Global clinical trial testing service from our clinical laboratories, including a menu of platforms & assays and an integrated specimen collection & logistics service. Find Out More www.almacgroup.com/diagnostics | The Almac Group is an established contract development and manufacturing organization providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Almac possesses a wealth of technical expertise to support the delivery of your complex projects. Our scientists can develop your clinical candidate into an optimum formulation, and solid manufacture oral dose products for all stages of clinical trials. Almac’s integrated pharmaceutical development solutions are tailored to meet your needs. We specialise in the manufacture & primary packaging of solid, oral dosage forms (Tablets, Capsules and Powders). As well as customised secondary packaging for all drug products including ultra-low temperature drug products. Almac works in close partnership with our clients offering unique solutions designed to support the efficient and successful development, and commercialisation of new treatment options. | Operating from state-of-the-art facilities in the US, Europe, and the UK, Almac Pharma Services is a FDA, HPRA, and MHRA approved CDMO partnering with global pharmaceutical and biotechnology industries. We have over 50 years’ experience in providing a comprehensive range of tailored solutions. Providing end-to-end integrated solutions to bring your drug product from development through to commercialisation from a single source. We work with clients to provide pharmaceutical development, manufacturing, product launch, and packaging solutions to fit their unique needs. Our team of experts can support the development of fit-for-purpose formulation for First-in-Human trials, to developing a more robust formulations scaling up for late phase trials, and ultimately commercialisation. Supporting key development and manufacture areas such as paediatrics, potent and highly potent products. We provide primary and secondary packaging for all drug products including ultra-low temperature drug products and specialised kit assembly. Almac was one of the 1st EU CDMOs to support gene therapy product launches, and currently supports 25% of EU approved/pre-registration Gene Therapy solutions. We provide end-to-end management of drug product supply, including distribution, packaging design, and support initial and ongoing global product launch. We provide unique, tailormade solutions designed to support the efficient and successful development, and commercialisation of new treatment options. Partnering with our clients to provide flexible, stable, ongoing supply to meet their product pipeline needs. | The Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle. A privately owned organisation, under the McClay Foundation, Almac has grown organically over the past five decades, now employing over 7,500 highly skilled individuals across 18 locations in Europe, the US and Asia. Almac Group is comprised of 5 Business Units: • Almac Diagnostic Services • Almac Sciences • Almac Pharma Services • Almac Clinical Services • Almac Clinical Technologies Each Business Unit offers specialist and dedicated solutions at each phase of the product lifecycle providing the ability to select single or multiple, integrated solutions to meet your unique needs. Our unique combination of inspirational people, exceptional innovation and outstanding quality, enables us to provide tailored solutions for your specific requirements – either on a single, standalone project or on a long-term basis as your strategic partner. About Almac Pharma Services: With over 55 years’ experience, Almac Pharma Services is an established, reliable and world leading outsourcing partner to the global pharmaceutical and biotechnology industry. Employing over 1,800 highly skilled individuals across 4 locations in Europe and the US, we provide a range of tailored, quality-led and timely solutions from early and late phase pharmaceutical development, clinical and commercial drug product manufacture, product launch through to commercial packaging and global distribution. Currently supporting client portfolios across more than 70 countries, our fully integrated, end-to-end solutions are tailored to meet the needs of your unique products, and, ultimately, your patients. Pharmaceutical Development Solutions: Spanning both early and late phase development, our teams of expert scientists possess a wealth of experience in developing clinical candidates into optimal formulations and manufacturing high-quality oral dose products for all phases of clinical trials. Operating both non-GMP and GMP facilities we have complementary equipment trains and integrated technical teams to facilitate technology transfer providing a seamless transition between formulation and process development, and clinical trial material manufacturing. Through a range of flexible and fully tailored unit operations including blending, roller compaction, high shear granulation, encapsulation (including Xcelodose) micro encapsulation and fluid bed processing, we offer the following oral dose formulations with batch sizes ranging from grams to tons: • API / powder in hard gelatin capsules or bottles, including micro-dosing • Formulated blends in hard gelatin capsules or bottles • Tablets (coated) • Mini-tablets • Granules • Beads/pellets • Non-sterile liquid in capsules or bottles • Immediate and modified release • Fixed dose combination products • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug development expertise Analytical Solutions: We employ over 700 highly skilled analysts working in state-of-the-art, fully certified GMP laboratories across Europe and the US with significant experience in the analysis of both small and large molecules. We support drug substance (API) and drug product (finished product) analytics across all phases of clinical development through to commercial release. We offer a range of tailored services including: • Method development • Method validation • Method transfer • Stability programmes • Release analysis: all lifecycle stages • Spectroscopy services • Investigational analysis • Reference standard management • Microbiological testing • Physical sciences • Bio-pharmaceutical testing • Analytical support for clinical trial supplies Commercial Manufacture Solutions: Scaling up from our oral dose development assets and expertise through registration and launch into commercial supply, or transferring existing commercial products, we support your commercial manufacturing needs with flexibility and expertise. With blend sizes from 10kgs up to 2.5 tons, our range of state-of-the-art processing equipment is designed to enable scalability to the batch size requirements of your product for a range of presentations including: • Tablets • Mini-tablets • Capsules • Powders • Granules • Beads/pellets • Non-sterile liquids • Potent and highly potent products (OEL as low as 0.05 ug/m3/8 hours) • Specialist paediatric drug manufacturing expertise Commercial Packaging Solutions: Our high and low throughput operations provide the flexibility and efficiency necessary to meet your ongoing and fluctuating demand. Our commercial facilities in Europe and the US, combined with our local expertise offers flexible, quality-led commercial pharmaceutical packaging solutions tailored to meet your specific needs. Our range of primary packaging solutions include: • Tablets • Mini-tablets • Capsules • Powders • Granules • Non-sterile liquid • Our secondary packaging, labelling and assembly capabilities include: • Bottles Vials / ampoules • Pre-filled syringes • Wallets / blister cards • Auto-injectors • Cartons • Sachets • Stick packs • Offline blister printing Innovative, specialist packaging solutions including: • Specialist paediatric drug packaging expertise • Expert cell and gene therapy (ATMP) Ultra Low Temperature (ULT) solutions (-20° to -80°) • Complex medical kit assembly solutions via our unique, custom built semi-automated packaging technology Support Solutions: We provide a wide range of tailored support and consultancy services to help guide you through every aspect of your unique development and commercialisation journey. Find out more – www.almacgroup.com
Aladdin Scientific
About Aladdin “Aladdin: Fueling Discoveries, Advancing Science.” At Aladdin, we blend cutting-edge science with relentless progress. Established in 2009, we’re renowned for our superior reagents, ranging from chemicals and biochemicals to proteins and antibodies. With over 700 employees across global offices in the US, Germany, Ireland, Singapore, and China, and powered by three manufacturing facilities and two R&D Centers, our commitment to scientific excellence and product quality is unwavering. Our Vision Aladdin is a beacon in the technological and innovative landscape, symbolizing a future driven by scientific discovery. We believe in the transformative power of science — its ability to change societies and elevate lives. Our ethos is embodied in every product we create and every service we offer. Precision-Driven Research In the realm of research and development, precision is paramount. Our life science tools are designed for unmatched accuracy, ensuring research that’s not only efficient but also exceptionally precise. Our goal is clear and steadfast: to deliver precision-guided results and build trust through superior outcomes. | Aladdin, established in 2009, is a pioneer in scientific innovation, offering superior reagents, chemicals, and life science tools. With a global workforce of over 700 and facilities across the US, Germany, Ireland, Singapore, and China, we’re committed to excellence in research and development. Our vision is a future shaped by scientific discovery, driving societal transformation and enhancing lives. Precision and innovation lie at the heart of our operations, guiding our quest for groundbreaking solutions. Join aladdinsci.com on a journey of scientific exploration, where each advancement opens doors to a brighter, more innovative future.
ACROBiosystems
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England and Germany. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics. ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics. Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.
ACD, a Bio-Techne brand
Bio-Techne’s leading spatial biology brands, ACD and Lunaphore, are transforming the future of research and precision medicine. From low-plex chromogenic to high-plex fluorescent assays, the scalable platforms and fully automated same-section multiomics workflows bring unmatched performance and flexibility to scientists. Powered by the gold-standard RNAscope™ technology & Lunaphore’s flagship end-to-end fully automated COMET™ product suite, Bio-Techne equip researchers with the right tools!
Abnova Corporation
Abnova Corporation is a leading provider of research and GMP-grade reagents with over 20 years of experience in life science innovation. Our comprehensive portfolio includes antibodies, NanoAb™, recombinant proteins, ELISA kits, FISH probes, circRNA sponges, RNA laboratory reagents, and CellTx™ cell therapy solutions. We also offer integrated custom services, including recombinant antibody and protein production, VHH development, antibody engineering and humanization, assay kit development, DNA/RNA probe design, nanoCAR-T mRNA services, IVT mRNA, LNP, and analytical services, as well as orthotopic and PDX mouse models, supporting applications from basic research to preclinical development. Abnova’s new RNAutomation™ is an automated platform for mRNA synthesis and purification, supporting in vitro transcription, capping, oligo-dT and cellulose purification. Built on an open-ended Opentron Flex™ system, RNAutomation™ proprietary software, vacuum manifold module, and reagent upgrades provide a fast turn-key solution for high purity, yield, and reproducible mRNA production. RNAutomation™ is amenable to add-on modules and customized software for task-oriented missions. Abnova also provides a large portfolio of pre-validated NanoAb™ antibodies for direct sequence integration into mRNA, accelerating new RNA biologics for immunotherapy, cell therapy, and gene editing.
ABclonal Technology
ABclonal Technology accelerates the accuracy and precision of cancer research through our comprehensive catalog of high-quality, personalized reagents and services. Our innovative SMab™ technology, the first antibody discovery platform using single primary B cell ex vivo expansion, has produced PathoQ® for precision pathological immunohistochemistry, ABflo® for superior flow cytometry, and custom antibodies for novel targets. Our quantitative PCR mixes and kits marry cost effectiveness with superior results for your genomic analysis. Our versatile research tools cover targets impacting the study of apoptosis, autophagy, metabolism, metastasis, immune evasion, and more, with the ability to analyze tumor biology at multiple levels. Please visit abclonal.com for product information and quote requests.
AAT Bioquest Inc
AAT Bioquest Inc. is a leading manufacturer and supplier of bioreagents and assay kits, dedicated to advancing scientific research and innovation. Known for producing high-quality and reliable products, AAT Bioquest offers a comprehensive portfolio including fluorescent probes, bioluminescent assays, enzyme substrates, and cell-based assays. Our catalog of over 5000 products features patented technologies such as Fluo-8® and Cal-520® calcium dyes, iFluor® dyes, CytoTell® proliferation dyes, Amplite® Assay Kits, and Buccutite™ conjugation kits. Our innovative solutions cater to a wide range of life science applications, including drug discovery, molecular biology, and clinical diagnostics. AAT Bioquest is committed to excellence, demonstrated by rigorous quality control, exceptional technical support, and continuous product development. Researchers globally trust our cutting-edge reagents for their accuracy, reproducibility, and sensitivity. Headquartered in Pleasanton, California, AAT Bioquest operates with a global distribution network ensuring our products reach scientists worldwide.
3DHISTECH
DHISTECH’s Pannoramic Pathology System is a complex package of instruments and software supported by one vendor. It covers each stage of the pathology workflow in research and diagnostics, by providing solutions to the complete digitization process of histology, cytology and hematology samples and case management through its functions and features.